| Clotilde Théry | |
| Nationality: | French |
| Fields: | Cellular biology, molecular biology, immunology |
| Workplaces: | Institut Curie |
| Education: | College de France, Paris (PhD, 1991) Oxford University, United Kingdom Columbia University, New York Institut Curie, France |
| Academic Advisors: | S. Amigorena |
| Known For: | Research on the immunology of extracellular vesicles; President, International Society for Extracellular Vesicles |
| Awards: | International Society for Extracellular Vesicles Special Achievement Award (2014) |
Clotilde Théry is a professor and INSERM director of research (DR2) at Institut Curie in Paris, France.[1] [2] She is president of the International Society for Extracellular Vesicles (ISEV), where she previously served as founding secretary general and as editor-in-chief of the Journal of Extracellular Vesicles. She is team leader of the group "Extracellular Vesicles, Immune Responses and Cancer" within the INSERM Unit 932 on "Immunity and Cancer." Théry researches extracellular vesicles that are released by immune and tumor cells, including exosomes that originate in the multivesicular body.
After a PhD in France, Théry completed a first post-doctoral fellowship in the United Kingdom and the United States in the field of developmental biology of the nervous system. Returning to France, Théry next took up the topic of cell biology of immune responses at Institut Curie.
Théry began studying exosomes in 1998, at a time when EVs were considered to be uninteresting or even artifacts.[3] In 2007, Théry's current team on Extracellular Vesicles, Immune responses and Cancer was started at Institut Curie, now a member of the PSL Research University.
Théry's lab is interested in how EVs, including exosomes, mediate communication between cells of the immune system and cancer cells. She is the most cited author of several cell biology journals: Annual Review of Cell and Developmental Biology, Current protocols in cell biology, Journal of Extracellular Vesicles.[4]